Literature DB >> 32458547

Decline in invasive pneumococcus diseases while combating the COVID-19 pandemic in Taiwan.

Jong-Rung Tsai1, Chih-Jen Yang2, Wei-Ling Huang2, Yen-Hsu Chen3,4,5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32458547      PMCID: PMC7283704          DOI: 10.1002/kjm2.12233

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


× No keyword cloud information.
Dear Editor: SARS‐CoV2 (COVID19) is the novel coronavirus that is currently causing the critical public threat worldwide. COVID19 is transmitted through at least droplet and contact transmission routes. Since the start of the COVID‐19 pandemic, the Taiwan government has taken many proactive and aggressive actions to prevent the transmission of COVID‐19, and there are still fewer than 400 confirmed cases of COVID‐19 to date. These proactive strategies include wearing a facemask. A pooled analysis of observational studies based on the experience of severe acute respiratory syndrome (SARS) in 2003 disclosed the benefit of wearing masks (OR = 0.13; 95% CI: 0.03‐0.62) to protect against the disease in healthcare workers. Therefore, in February, the Taiwan government stated that all healthcare workers and people in crowded places or in public must wear facemasks to protect them from COVID‐19 infection, even though the role of facemasks in the battle against COVID‐19 is still controversial. Many efforts have been taken to ensure that facemasks are available and that there is sufficient supply for healthcare workers and most people in Taiwan. The production capacity of facemasks has increased from 1.3 millions per day in January to 13 millions per day in April. In addition to wearing facemasks, hand hygiene, environmental disinfection, and social distancing are also strongly recommended by the Taiwan government. According to the Taiwan CDC, there has been a marked decline in invasive pneumococcus disease since February 2020 compared with cases in the past 5 years (Figure 1). Streptococcus pneumoniae can spread through droplets in the air as with COVID‐19, and S pneumoniae may enter and remain in the nose and throat. The incubation period of S pneumoniae is about 1 to 3 days, after which it can invade the lungs, blood, sinuses, middle ear, or brain, potentially leading to a severe and fatal infection. “Invasive pneumococcal disease” is defined as an infection confirmed by the isolation of S pneumoniae from a normally sterile site, such as blood, cerebrospinal fluid, and pleural, joint, or peritoneal fluid. Invasive pneumococcus is a notifiable disease, and it must be reported to the Taiwan CDC within 1 week.
FIGURE 1

The number of cases of reported invasive pneumococcus from 2016 to 2020 according to the Taiwan CDC (https://www.cdc.gov.tw/)

The number of cases of reported invasive pneumococcus from 2016 to 2020 according to the Taiwan CDC (https://www.cdc.gov.tw/) We believe that the reduction in invasive pneumococcus disease has been influenced by the current preventive strategies for COVID‐19 in Taiwan.
  5 in total

Review 1.  Upper respiratory tract colonization with Streptococcus pneumoniae in adults.

Authors:  Adriano Arguedas; Krzysztof Trzciński; Katherine L O'Brien; Daniela M Ferreira; Anne L Wyllie; Daniel Weinberger; Leon Danon; Stephen I Pelton; Chiara Azzari; Laura L Hammitt; Raquel Sá-Leão; Maria-Cristina C Brandileone; Samir Saha; Jose Suaya; Raul Isturiz; Luis Jodar; Bradford D Gessner
Journal:  Expert Rev Vaccines       Date:  2020-04-17       Impact factor: 5.217

Review 2.  A visual review of the human pathogen Streptococcus pneumoniae.

Authors:  Ditte Høyer Engholm; Mogens Kilian; David S Goodsell; Ebbe Sloth Andersen; Rikke Schmidt Kjærgaard
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

Review 3.  Effectiveness of Masks and Respirators Against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis.

Authors:  Vittoria Offeddu; Chee Fu Yung; Mabel Sheau Fong Low; Clarence C Tam
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

4.  Rational use of face masks in the COVID-19 pandemic.

Authors:  Shuo Feng; Chen Shen; Nan Xia; Wei Song; Mengzhen Fan; Benjamin J Cowling
Journal:  Lancet Respir Med       Date:  2020-03-20       Impact factor: 30.700

5.  COVID-19: Face masks and human-to-human transmission.

Authors:  Xiaopeng Liu; Sisen Zhang
Journal:  Influenza Other Respir Viruses       Date:  2020-04-05       Impact factor: 4.380

  5 in total
  3 in total

1.  Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan.

Authors:  Muhammad Suleman Rana; Muhammad Usman; Muhammad Masroor Alam; Aamer Ikram; Muhammad Salman; Syed Sohail Zahoor Zaidi; Massab Umair; Mehmood Qadir
Journal:  J Infect       Date:  2021-01-29       Impact factor: 6.072

2.  The Collateral Effect of COVID-19 on the Epidemiology of Airborne/Droplet-Transmitted Notifiable Infectious Diseases in Taiwan.

Authors:  Hung-Jen Tang; Chih-Cheng Lai; Chien-Ming Chao
Journal:  Antibiotics (Basel)       Date:  2022-04-03

Review 3.  A North-South Problem in Civic-Tech and Volunteered Geographic Information as Countermeasures of COVID-19: A Brief Overview.

Authors:  Koshiro Suzuki
Journal:  SN Comput Sci       Date:  2022-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.